Value to our shareholders
We create value through strong individual market performance and pipeline developments. Investors are attracted by our portfolio of products, our adjuvant technologies and our commitment to innovation through R&D.
Share price summary
Our year in numbers
2018 was a year of continued growth with constant currency growth of 3.5% a one point increase in our market share to 14% and an increase in operating profit ore R&D of 26%.
Preliminary Results announcement 2018
Allergies reduce quality of life by preventing individuals and their loved ones from enjoying the everyday activities most take for granted. At their most severe, they can be fatal.
Transforming lives
Specialist expertise drives and inspires us to discover more, helping us to improve patients' lives.
Specialist expertise
To achieve our vision and fulfil our mission, we develop treatments that are as convenient as they are effective.
Delivering convenience
Take your career to new heights
Our culture and values